| Lyotropic liquid crystal systems in drug delivery: a review DH Kim, A Jahn, SJ Cho, JS Kim, MH Ki, DD Kim Journal of Pharmaceutical Investigation 45, 1-11, 2015 | 118 | 2015 |
| Obesity-related physiological changes and their pharmacokinetic consequences SJ Cho, IS Yoon, DD Kim Journal of Pharmaceutical Investigation 43, 161-169, 2013 | 48 | 2013 |
| In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism SB Kim, IS Yoon, KS Kim, SJ Cho, YS Kim, HJ Cho, SJ Chung, S Chong, ... Planta Medica 80 (07), 561-567, 2014 | 42 | 2014 |
| Effects of nonalcoholic fatty liver disease on hepatic CYP2B1 and in vivo bupropion disposition in rats fed a high-fat or methionine/choline-deficient diet SJ Cho, SB Kim, HJ Cho, S Chong, SJ Chung, IM Kang, JI Lee, IS Yoon, ... Journal of agricultural and food chemistry 64 (27), 5598-5606, 2016 | 18 | 2016 |
| 17β-Estradiol up-regulates UDP-glucuronosyltransferase 1A9 expression via estrogen receptor α S Cho, M Ning, Y Zhang, LH Rubin, H Jeong Acta Pharmaceutica Sinica B 6 (5), 504-509, 2016 | 17 | 2016 |
| Fructose diet alleviates acetaminophen-induced hepatotoxicity in mice S Cho, A Tripathi, G Chlipala, S Green, H Lee, EB Chang, H Jeong PLoS One 12 (8), e0182977, 2017 | 14 | 2017 |
| Phenylpropionic acid produced by gut microbiota alleviates acetaminophen-induced hepatotoxicity S Cho, X Yang, KJ Won, VA Leone, EB Chang, G Guzman, Y Ko, ON Bae, ... Gut Microbes 15 (1), 2231590, 2023 | 13 | 2023 |
| Absorption, metabolism and excretion of pictilisib, a potent pan-class I phosphatidylinositol-3-Kinase (PI3K) inhibitor, in rats, dogs, and humans Q Yue, SC Khojasteh, S Cho, S Ma, T Mulder, J Chen, J Pang, X Ding, ... Xenobiotica 51 (7), 796-810, 2021 | 7 | 2021 |
| Biotransformation novel advances–2021 year in review SC Khojasteh, UA Argikar, S Cho, R Crouch, CJS Heck, KM Johnson, ... Drug metabolism reviews 54 (3), 207-245, 2022 | 4 | 2022 |
| Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage J Cai, A Auster, S Cho, Z Lai Journal of Advanced Research 52, 171-201, 2023 | 2 | 2023 |
| Absorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and Humans S Ma, S Cho, S Sahasranaman, W Zhao, J Pang, X Ding, B Dean, B Wang, ... Drug Metabolism and Disposition 51 (4), 436-450, 2023 | 2 | 2023 |
| Elucidating the structure and cytochrome P450-mediated mechanism for novel metabolites of GDC-0575 in rats C Zhang, S Cho, JG Napolitano, D Russell, C Gu, A Deese, C Han, ... Xenobiotica 52 (3), 219-228, 2022 | 2 | 2022 |
| Biotransformation research advances–2022 year in review SC Khojasteh, UA Argikar, L Cheruzel, S Cho, RD Crouch, D Dhaware, ... Drug Metabolism Reviews 55 (4), 301-342, 2023 | 1 | 2023 |
| Bioactivation and reactivity research advances–2021 year in review KD Jackson, UA Argikar, S Cho, RD Crouch, JP Driscoll, CJS Heck, ... Drug metabolism reviews 54 (3), 246-281, 2022 | 1 | 2022 |
| Absorption, metabolism, and excretion of inavolisib (GDC-0077), a PI3KA inhibitor in humans S Cho, S Ma, R Johnson, S Cheeti, C Khojasteh, D Zhang, L Salphati Drug Metabolism and Pharmacokinetics 55, 100922, 2024 | | 2024 |
| Bioactivation and reactivity research advances–2022 year in review S Wang, UA Argikar, L Cheruzel, S Cho, RD Crouch, D Dhaware, ... Drug Metabolism Reviews 55 (4), 267-300, 2023 | | 2023 |
| The Absolute Bioavailability and Absorption, Metabolism, and Excretion of Ipatasertib, a Potent and Highly Selective Protein Kinase B (Akt) Inhibitor RH Takahashi, V Malhi, BM Liederer, S Cho, Y Deng, B Dean, J Nugteren, ... Drug Metabolism and Disposition 51 (10), 1332-1341, 2023 | | 2023 |
